Efficacy and Safety Evaluation of Nabilone as Adjunctive Therapy to Gabapentin for the Management of Neuropathic Pain in Multiple Sclerosis

NCT00480181 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Neuropathic Pain
Multiple Sclerosis

Interventions

DRUG: nabilone
OTHER: placebo

Sponsor

University of Manitoba

Collaborators

[object Object]